JP Morgan Chase
GMAB icon

JP Morgan Chase’s Genmab GMAB Stock Holding History

JP Morgan Chase’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-80,000
Closed -$2.63M – 6435
2021
Q1 		$2.63M Buy
+80,000
New +$3.01M ﹤0.01% 3494
2020
Q3 		– Sell
-37,500
Closed -$1.27M – 5576
2020
Q2 		$1.27M Buy
+37,500
New +$1.02M ﹤0.01% 3380

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

JP Morgan Chase's GMAB Position: Q2 2026 in Review

JP Morgan Chase increased its Genmab (GMAB) stake by 235% in Q2 2026, buying an estimated $13.9M and bringing the position to 744,815 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2248.

JP Morgan Chase first reported a position in GMAB in Q3 2019 and has held it in 28 quarters since. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • JP Morgan Chase held 744,815 shares of Genmab worth $19.4M as of Q2 2026.
  • JP Morgan Chase bought 522,208 Genmab shares in Q2 2026, an estimated $13.9M.
  • Genmab made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2248 holding.
  • JP Morgan Chase first reported a position in Genmab in Q3 2019 and has held it in 28 quarters since.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.